ABVX Latest Headlines

ABVX Faces Shareholder Investigation as Rare Malignancy Cases Surface in Phase 3 Trial

Market Chameleon (Thu, 4-Jun 11:08 AM)

This Is Why Abivax Stock (ABVX) Is Up Today

at www.tipranks.com (Wed, 3-Jun 2:41 PM)

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and MaxCyte (MXCT)

at www.tipranks.com (Wed, 3-Jun 1:30 PM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)

at www.tipranks.com (Wed, 3-Jun 4:10 AM)

Leerink Partners Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)

at www.tipranks.com (Tue, 2-Jun 8:37 AM)

Analysts’ Top Healthcare Picks: Abivax SA Sponsored ADR (ABVX), IDEAYA Biosciences (IDYA)

at www.tipranks.com (Tue, 2-Jun 8:30 AM)

Wall Street Analysts Are Bullish on Top Healthcare Picks

at www.tipranks.com (Tue, 2-Jun 7:40 AM)

At a glance: stocks gapping down premarket

at seekingalpha.com (Tue, 2-Jun 7:22 AM)

Analysts Offer Insights on Healthcare Companies: ImmunityBio (IBRX), Abivax SA Sponsored ADR (ABVX) and Precigen (PGEN)

at www.tipranks.com (Tue, 2-Jun 7:10 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Nuvalent (NUVL), Abbott Laboratories (ABT) and Abivax SA Sponsored ADR (ABVX)

at www.tipranks.com (Tue, 2-Jun 5:50 AM)

European stocks regain footing; investors await key war fallout data

at seekingalpha.com (Tue, 2-Jun 4:31 AM)

Abivax drops 32% as ulcerative colitis drug efficacy overshadowed by cancer concerns

at seekingalpha.com (Tue, 2-Jun 4:23 AM)

Abivax plunges 32% as ulcerative colitis drug efficacy overshadowed by cancer concerns

at seekingalpha.com (Tue, 2-Jun 4:23 AM)

ABVX Phase 2 Data Draws Spotlight to Chronic Inflammatory Disease Innovation

Market Chameleon (Thu, 28-May 8:40 AM)

Abivax Shareholders Green-Light All Proposals at 2026 Annual General Meeting: Focus Sharpens on Phase 3 Developments

Market Chameleon (Tue, 12-May 9:13 AM)

Abivax Locks in $45M Offering and Retires Royalty Certificates, Extending Cash Runway Into Q4 2027

Market Chameleon (Tue, 5-May 7:08 AM)

Abivax Highlights Comprehensive Obefazimod Data at Upcoming Digestive Disease Week Conference

Market Chameleon (Thu, 23-Apr 8:27 AM)

Abivax Releases Full Preparatory Documents for May 2026 Shareholder Meeting: What Should Investors Watch?

Market Chameleon (Tue, 21-Apr 7:14 AM)

Abivax Releases 2025 Financial Reports—Key Filings Set the Stage for Phase 3 Ulcerative Colitis Trials

Market Chameleon (Thu, 2-Apr 7:08 AM)